Brain PET imaging reveals role of serotonin in Alzheimer's disease
January 11, 2023 -- PET imaging has shown a link between serotonin brain activity in early Alzheimer's disease patients to beta-amyloid plaque deposits, a hallmark of the condition, according to a study published online on January 6 in NeuroImage: Clinical. Read More
PET tracer may improve prostate cancer imaging
January 10, 2023 -- PET/CT imaging with an experimental F-18 prostate-specific membrane antigen radiotracer improves the care of patients with recurrent prostate cancer, according to a study published on January 7 in Research in Diagnostic and Interventional Imaging. Read More
AI model predicts cancer aggressiveness on PET
January 10, 2023 -- A machine-learning model based on PET imaging features shows promise for helping clinicians assess the aggressiveness of endometrial cancer prior to surgery, according to a study published online January 4 in Cancers. Read More
Brain PET/MRI scans reveal visual snow syndrome
January 9, 2023 -- PET/MRI scans have revealed significant structural and metabolic brain abnormalities in patients with visual snow syndrome, according to a study published December 30 in EJNMMI Research. Read More
FDA approves new drug for Alzheimer's disease
January 6, 2023 -- Japanese drug developer Eisai has received U.S. Food and Drug Administration (FDA) approval for its Leqembi (lecanemab) treatment for individuals with Alzheimer's disease. The drug is the second of a new category of medications for the disease to go through the FDA's accelerated regulatory pathway. Read More
PSMA-PET shows value in primary staging of prostate cancer
January 6, 2023 -- Prostate-specific membrane antigen (PSMA) PET/CT imaging can reveal metastatic bone cancer lesions in prostate cancer patients that may be undetected by conventional bone scintigraphy, according to a group in the Netherlands. Read More
FAPI-PET shows promise over conventional PET for identifying cancer
January 5, 2023 -- Gallium-68 fibroblast activation protein inhibitor (FAPI) PET imaging may improve tumor detection in cancer patients over conventional imaging, according to a study published December 30 in the Journal of Nuclear Medicine. Read More
PET tracer shows promise in imaging of brain tumors
January 4, 2023 -- A widely available amino acid PET radiotracer shows promise in helping clinicians distinguish between pseudoprogression and actual tumor progression in patients with brain tumors, according to a study published December 22 in the Journal of Nuclear Medicine. Read More
PET/CT score may help predict major cardiac events
January 4, 2023 -- Researchers have developed a clinical tool based on standard PET/CT imaging that could help cardiologists identify patients at high risk for heart attack and stroke, according to a study published online December 19 in the Journal of Nuclear Cardiology. Read More
Bone scan capacity increased to meet COVID-19 backlog
January 3, 2023 -- Radiologists in England facing a backlog of bone scan procedures for prostate cancer patients have developed a strategy for optimizing appointments that can significantly increase capacity, according to a study presented recently at RSNA 2022 in Chicago. Read More
Special Feature
Ringertz: Nobel prize for PET may lie on the horizon

A Nobel prize for PET imaging could well be on the cards in the years ahead, but identifying the most deserving recipient(s) is no simple task, Prof. Hans Ringertz revealed during ECR 2022. Read more

Industry News
VENDOR CONNECT
Conferences
Lung Cancer Staging Study Day
February 23
Virtual, London, City of United Kingdom
Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics
May 4-6
Las Vegas, Nevada United States
Diagnostic Imaging Update at Banff
July 31 - August 3
Banff Springs, Alberta Canada